Dr. Kathryn M. Leininger
Claim this profileCleveland Clinic Akron General
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
34 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Kathryn M. Leininger is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria
More about Kathryn M. Leininger
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Kathryn M. Leininger has experience with
- Biospecimen Collection
- Oxaliplatin
- Fluorouracil
- Questionnaire Administration
- Paclitaxel
- Pembrolizumab
Breakdown of trials Kathryn M. Leininger has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathryn M. Leininger specialize in?
Kathryn M. Leininger focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Kathryn M. Leininger currently recruiting for clinical trials?
Yes, Kathryn M. Leininger is currently recruiting for 6 clinical trials in Akron Ohio. If you're interested in participating, you should apply.
Are there any treatments that Kathryn M. Leininger has studied deeply?
Yes, Kathryn M. Leininger has studied treatments such as Biospecimen Collection, Oxaliplatin, Fluorouracil.
What is the best way to schedule an appointment with Kathryn M. Leininger?
Apply for one of the trials that Kathryn M. Leininger is conducting.
What is the office address of Kathryn M. Leininger?
The office of Kathryn M. Leininger is located at: Cleveland Clinic Akron General, Akron, Ohio 44307 United States. This is the address for their practice at the Cleveland Clinic Akron General.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.